Loading...
CGTX COGNITION THERAPEUTICS INC US FDA Inspections 8-K Filing
Back
CGNT
CGTX
COGNITION THERAPEUTICS INC
(CGTX)
Follow
FY2023 8 K
View More
Back
CGNT
CGTX
COGNITION THERAPEUTICS INC
(CGTX)
Follow
FY2023 8 K
Filing:
8 K
Published on:
22 Feb '23
Financial Results
20 Mar '25
Nasdaq Notification
12 Mar '25
Study Update
26 Feb '25
Investor Presentation
28 Jan '25
Investor Presentation
13 Jan '25
Study Data Release
18 Dec '24
Financial Results
13 Nov '24
Investor Presentation
1 Oct '24
Nasdaq Deficiency Notice
13 Sep '24
Investor Presentation
28 Aug '24
Financial Results Announcement
8 Aug '24
Filing
29 Jul '24
Annual Meeting Voting Results
7 Jun '24
Financial Results Announcement
7 May '24
Financial Results Announcement
26 Mar '24
Public Offering
13 Mar '24
Financial Results
11 Mar '24
Grant of Performance Restri...
20 Feb '24
Investor Presentation
4 Jan '24
Financial Results Announcement
2 Nov '23
Exhibit Attached
12 Sep '23
Regulation FD Disclosure
24 Aug '23
Financial Results Announcement
8 Aug '23
Phase 2 Study Results
28 Jun '23
Annual Meeting of Stockholders
12 Jun '23
Financial Results Announcement
4 May '23
Appointment of CFO
1 May '23
Regulation FD Disclosure
19 Apr '23
Other Events
28 Mar '23
Financial Results Announcement
23 Mar '23
FDA Clearance for CT1812 Dr...
15 Mar '23
Regulation FD Disclosure
10 Mar '23
Purchase Agreement with Lin...
10 Mar '23
FDA Clearance for Phase 2 S...
22 Feb '23
FDA Clearance for CT1812
13 Feb '23
External Links:
SEC
AI Assistant
Close
COGNITION THERAPEUTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.